Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a... AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 2.98507462687 | 2.68 | 2.96 | 2.64 | 6474 | 2.77970184 | CS |
| 4 | -0.17 | -5.80204778157 | 2.93 | 3.13 | 2.38 | 9412 | 2.73091181 | CS |
| 12 | -0.14 | -4.8275862069 | 2.9 | 3.7064 | 2.38 | 7769 | 2.94042085 | CS |
| 26 | -3.82 | -58.0547112462 | 6.58 | 6.58 | 2.38 | 7743 | 3.46117271 | CS |
| 52 | -3.455 | -55.5913113435 | 6.215 | 6.7738 | 2.38 | 7650 | 3.49303182 | CS |
| 156 | -3.455 | -55.5913113435 | 6.215 | 6.7738 | 2.38 | 7650 | 3.49303182 | CS |
| 260 | -3.455 | -55.5913113435 | 6.215 | 6.7738 | 2.38 | 7650 | 3.49303182 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
